SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

09 Aug 2024 Evaluate
The Sales for the quarter ended June 2024 of Rs. 41602.00 millions rose by 40.75% from Rs. 29557.00 millions.The company almost doubled its revenue to Rs. 17008.00 millions  from Rs. 7809.00 millions in the quarter ended June 2024.The company reported a good operating profit of 24795.00 millions compared to 12234.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 41602.00 29557.00 40.75 41602.00 29557.00 40.75 108187.00 87316.00 23.90
Other Income 1066.00 824.00 29.37 1066.00 824.00 29.37 11595.00 8219.00 41.08
PBIDT 24795.00 12234.00 102.67 24795.00 12234.00 102.67 51435.00 30028.00 71.29
Interest 1154.00 897.00 28.65 1154.00 897.00 28.65 3907.00 2782.00 40.44
PBDT 23641.00 11337.00 108.53 23641.00 11337.00 108.53 47442.00 25208.00 88.20
Depreciation 1306.00 1212.00 7.76 1306.00 1212.00 7.76 5044.00 4886.00 3.23
PBT 22335.00 10125.00 120.59 22335.00 10125.00 120.59 42398.00 20322.00 108.63
TAX 5327.00 2316.00 130.01 5327.00 2316.00 130.01 7983.00 5030.00 58.71
Deferred Tax 11.00 -48.00 -122.92 11.00 -48.00 -122.92 -1360.00 412.00 -430.10
PAT 17008.00 7809.00 117.80 17008.00 7809.00 117.80 34415.00 15292.00 125.05
Equity 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59
PBIDTM(%) 59.60 41.39 43.99 59.60 41.39 43.99 47.54 34.39 38.25

Zydus Lifesciences Share Price

942.55 3.35 (0.36%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×